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Abstract
Two palladium/chiral diphosphine-catalyzed umpolung cyc-
lizations of aldehyde-containing allylic acetates and allenes
with arylboronic acid are fully investigated to establish key
factors in their high stereoselectivities. Both cyclization reac-
tions afford cis-disubstituted pyrrolidine and tetrahydrofuran.
These occur in high diastereo- and enantioselectivities through
a common cationic (Z)-η1-allylpalladium, toward which a ring
strain generated in the cyclization step leading to trans-isomers
biases the equilibrium through η3-η1-η3-complex in the former
cyclization. Varied diastereoselectivities were observed in the
formation of five-membered carbocycles and six-membered
heterocycles. These reflect release of a ring strain generated in
the cyclization step leading to trans-isomers and a different
distribution of the (Z)- and the (E)-η1-allylpalladium inter-
mediates generated by the oxidative addition of allylic acetates
to Pd(0) or carbopalladation of allenes, respectively. A steri-
cally demanding substituent at the center of the allyl moiety is
necessary for high diastereo- and enantioselectivity. The enan-
tioselectivity of the former cyclization was lowered by the
presence of organometallic reductants or reagents, possibly
causing the formation of neutral η1-allylpalladium species. We
used a chiral allylic acetate containing (E)-deuterium-labeled
alkene to demonstrate that the electrophilic attack of the alde-
hyde to the allyl ligand occurred on the side where the palla-
dium existed, consistent with the Zimmerman-Traxler transi-
tion state.
Keywords: Oxidative addition of allylic acetates j
Carbopalladation of allenes j Umpolung cyclization
1. Introduction
The allylpalladium species is one of the most versatile
intermediates in organic synthesis and it exists in equilibrium
between η3- and η1-complexes 2 and 6 with electrophilic and
nucleophilic properties, respectively (Scheme 1).1,2 In com-
bination with chiral ligands, both asymmetric allylation of
nucleophiles3 (Tsuji-Trost reaction) and electrophiles4 are
possible. η3-Allylpalladium 2 is readily formed by oxidative
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Scheme 1. Pd-catalyzed umpolung allylation of aldehydes
leading to homoallyl alcohol 5 through allylmetal 3a and
η1-allylpalladium 6.
Bull. Chem. Soc. Jpn. 2019, 92, 1743–1753 | doi:10.1246/bcsj.20190167 © 2019 The Chemical Society of Japan | 1743
addition of allylic acetate 1 to Pd(0), and undergoes nucleo-
philic substitution to afford Tsuji-Trost reaction product and
Pd(0), which enables the catalytic process.1 The isomerization
of η3- to η1-complex 6 and the subsequent electrophilic substi-
tution can lead to the umpolung allylation. Its catalytic reaction,
however, needs stoichiometric metallic reductants to convert
the resulting Pd(II) into Pd(0).2 The Et2Zn- or Et3B-mediated
catalytic and asymmetric nucleophilic allylation of aldehyde
4 was pioneered by Zanoni,4a while Minnaard4b and Zhou4c,4d
built upon the method and proposed that the organometallics
function as reducing alkylating agents, forming η1-allylpalla-
dium 6 bearing an Et group and a chiral monophosphorus
ligand. Previously, the asymmetric nucleophilic allylation was
considered unfeasible because Tamaru assumed allyl-zinc and­
borane 3a, generated by transmetalation of η3-allylpalladium 2
with Et2Zn or Et3B, were intermediates for the non-asymmetric
variant.2a The transmetalation of Pd(II) with either allylmetal
3b5­10 or a combination of organoboron reagent 7 and allene
811,12 is more suitable for the formation of η1-allyl complex 6,
because a reducing agent is unnecessary for its catalytic
nucleophilic allylation. However, a special ligand like bis(π-
allyl),5,6 PCP pincer,7,8 or N-heterocyclic carbene9,10 is neces-
sary to generate η1-allyl complex 6, which is in equilibrium with
2, but rarely detected. Nakamura and Yamamoto proposed η1-
allylpalladium 6 with a chiral π-allyl ligand as the intermediate
in enantioselective imine allylations.5 Consequently, any Pd-
catalyzed umpolung allylations involve stoichiometric metallic
reagents. Umpolung allylations not requiring metallic reagents
are advantageous: neither the stoichiometric metallic byprod-
ucts nor multiple allylmetal species (leading to difficult chiral
control) are generated.13,14
In contrast to the intermolecular asymmetric umpolung
allylation of aldehyde and imine functionalities under palla-
dium catalysis, the intramolecular variant remained undevel-
oped15 until we reported.12a,16 We expected that the umpolung
cyclization would occur more readily because thermodynami-
cally unstable η1-allylpalladium is effectively captured by the
adjacent electrophile and that the above special ligands are
unnecessary. Firstly, we developed the arylative cyclization of
allene-aldehyde 9 with arylboronic acid 7 under Pd(II) catalysis
to afford the homoallylic alcohol 11 in high diastereo- and
enantioselectivity (Scheme 2).12a We proposed the highly
stereoselective reaction originates from the Zimmerman-
Traxler transition state 1017­19 consisting of the aldehyde and
cationic η1-allylpalladium ligated with 5,5¤-bis(diphenylphos-
phino)-4,4¤-bi-1,3-benzodioxole (SEGPHOS, 12a), a commer-
cially available chiral diphosphine.20 However, the η1-allyl-
palladium derived from 9 can further react with 7, to produce
neutral (η1-allyl)arylpalladium, reported by Kurosawa,21
Szabo,7 Minnaard,4b and Zhou4d as nucleophilic (Scheme 3).
Secondly, to explore the participation of the aryl ligand in the
cyclization, we developed the Pd(0)/SEGPHOS or the DM-
SEGPHOS-catalyzed enantioselective cyclization of allylic
acetate-aldehyde 13 with the aid of a formate reductant.16 The
successful cyclization proved that the two cyclization reactions
proceed through the common cationic η1-allylpalladium and
that enantiodifferentiation happens in the aldehyde allylation
instead of in the allylpalladium formation. Interestingly, neither
Tsuji-Trost-type products 1422 and 1523 nor reduced products
16 and 16¤ formed, although formate can reduce η3-allylpalla-
dium.24 The latter cyclization is advantageous in: 1) there is
no need for metallic reagents to generate the stoichiometric
metallic byproducts and multiple allylmetal species; 2) it has
the ability to introduce a wide variety of substituent R (other
than aryl group) into the vinyl group of the products.
The two cyclization reactions proceed through a common
intermediate but yield different stereoselectivities, in some
cases. Although some related cis-selective cyclizations under
transition metal catalysis exist, the reason for the diastereo-
selectivity remains unclear.18,19,25 Herein, the two asymmetric
umpolung cyclization reactions are investigated to establish the
key factors responsible for the excellent stereoselectivity. In
addition to preliminarily reported data,12a,16 further experimen-
tal results are shown here to compare the effects of factors on
the stereoselectivity.
2. Experimental
General Procedure for Umpolung Cyclization of
Aldehyde-Containing Allylic Acetates («)-13a¢d­g¢j and
Carbonates («)-13b¢h¢i (Table 1, Entry 1, Table 2, Entry 2
and Scheme 5). To a test tube containing a solution of
(«)-13a¢b¢d­j (1.0 equiv) in anhydrous MeCN (0.05M) were
added Pd[P(o-tolyl)3]2 (10mol%), (S)-SEGPHOS or (S)-DM-
SEGPHOS (15mol%), and reductant (HCO2H-Bu3N (3.0
equiv) for 13a¢d­g¢j and HCO2H (1.0 equiv) for 13b¢h¢i)
under argon. The resulting mixture was sealed with a screw cap
and stirred at 50 °C. After starting material 13 was consumed,
the mixture was concentrated in vacuo. The residue was puri-
fied by preparative TLC to afford 11a¢d­j and 11(f­j)¤. Enan-
tiomeric excess of the products was determined by chiralHPLC.
The relative configuration was determined by NOESY correla-
tion. The absolute configurations were determined by modified
Mosher’s method26 using its (R)- and (S)-MTPA esters, which
were obtained by condensation of the products (DCC, DMAP
and DCM) with (R)- and (S)-Mosher’s acids, respectively.
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General Procedure for Phenylative Cyclization of Allene-
Aldehydes 9a¢e­j with Phenylboronic Acid (Table 4,
Entry 1 and Scheme 6). To a test tube containing a solu-
tion of 9a¢e­j (1.0 equiv) in anhydrous MeCN (0.1M) were
added Pd(OAc)2 (10mol%), (S)-SEGPHOS (10mol%), and
PhB(OH)2 (1.5 equiv) under argon. The resulting mixture was
sealed with a screw cap and stirred at 50 °C. After starting
material 9 was consumed, the mixture was cooled down to
room temperature and then treated with PS-DEAM MP resin·
(polymer-bound diethanolamine, 1.8mmol/g, 3.0 equiv) and
CHCl3 to remove an excess of PhB(OH)2. The mixture was
agitated at room temperature for 2 h, then filtered, and washed
with CHCl3 thoroughly. The filtrate was concentrated in vacuo.
The residue was purified by preparative TLC to afford 11a¢e­j
and 11(f­j)¤. Enantiomeric excess of the products was deter-
mined by chiral HPLC.
Phenylative Cyclization of Allene-Aldehyde 9a in THF
by Gradual Addition of PhB(OH)2 (Scheme 4). To a solu-
tion of 9a (12.0mg, 0.045mmol) in anhydrous THF (0.1M)
were added Pd(OAc)2 (1.0mg, 4.5¯mol) and (S)-SEGPHOS
(2.8mg, 4.6¯mol) under argon. To the stirring solution was
added 0.1M PhB(OH)2 (8.3mg, 0.068mmol) solution in anhy-
drous THF with a syringe pump over 2 h at 50 °C. The result-
ing mixture was stirred at the same temperature for another 5 h.
The mixture was cooled down to room temperature and then
treated with PS-DEAM MP resin· (1.8mmol/g, 3.0 equiv)
and CHCl3 to remove an excess of PhB(OH)2. The mixture was
agitated at room temperature for 2 h, then filtered, and washed
with CHCl3 thoroughly. The filtrate was concentrated in vacuo
and the residue was purified by preparative TLC (50% EtOAc/
hexane) to afford (3S, 4S)-11a (8.0mg, 0.023mmol, 52%,
95% ee).
Two-Step Conversion of 13l¤ into 11k via 11l (Scheme 8).
Reductive Cyclization of 13l¤: To a test tube containing a
solution of 13l¤ (E:Z = 1:2.5, 8.4mg, 0.023mmol) in anhy-
drous MeCN (0.05M) were added Pd[P(o-tolyl)3]2 (1.7mg, 2.4
¯mol), (S)-DM-SEGPHOS (2.5mg, 3.5¯mol), and HCO2H-
Bu3N (2.6¯L­16.0¯L, 0.069mmol) under argon. The resulting
mixture was sealed with a screw cap and stirred at 50 °C for
1.5 h. Then the mixture was concentrated in vacuo. The residue
was purified by preparative TLC (20% EtOAc/toluene) to
afford 11l (4.4mg, 0.015mmol, 64%). Enantiomeric excess
of 11l (87% ee) was determined by chiral HPLC (Daicel
Chiralpak AD-H, i-propanol/hexane = 10:90, 0.5mL/min,
λ = 254 nm): tR(3R, 4R) = 33.0min (minor enantiomer),
tR(3S, 4S) = 35.8min (major enantiomer).
Reduction of Cl Group in 11l: To a test tube containing a
solution of 11l (15.9mg, 0.053mmol, 87% ee) in anhydrous
DMA (0.2mL) were added PdCl2(PhCN)2 (2.0mg, 5.2¯mol),
dppf (3.2mg, 5.8¯mol), and HCO2Na (5.4mg, 0.079mmol)27
under argon. The resulting mixture was sealed with a screw cap
and stirred at 80 °C for 10 h. The mixture was treated with
water and the aqueous layer was extracted with EtOAc twice.
The combined organic layers were washed with brine, dried
over MgSO4, and concentrated in vacuo. The residue was puri-
fied by preparative TLC (20% EtOAc/toluene) to afford the
reduced product identical to (3S, 4S)-11k (13.1mg, 0.049
mmol, 93%). Chiral HPLC of the product (87% ee) showed
that optical purity of 11l was retained during the reduction.
One-Pot, Two-Step Conversion of 13n¤ into 11m via 11n
(Scheme 9). To a test tube containing a solution of 13n¤ (14.2
mg, 0.038mmol) in anhydrous MeCN (0.05M) were added
Pd[P(o-tolyl)3]2 (2.7mg, 3.8¯mol), (S)-SEGPHOS (3.5mg, 5.7
¯mol), and HCO2H-Bu3N (4.3¯L­25.9¯L, 0.114mmol) under
argon. The resulting mixture was sealed with a screw cap
and stirred at 50 °C for 24 h. The mixture was treated with PBu3
(2.0¯L, 8.1¯mol) and HCO2H-Bu3N (2.9¯L­17.3¯L, 0.077
mmol). After being stirred at 50 °C for another 6 h, the mixture
was concentrated in vacuo. The residue was purified by prepara-
tive TLC (20% EtOAc/toluene) to afford 11m (5.7mg, 0.025
mmol, 66%). After conversion of 11m (5.7mg, 0.025mmol) to
4-(prop-1-en-2-yl)-1-tosylpyrrolidin-3-ol (5.8mg, 0.021mmol,
82%) [1) TFA, CH2Cl2, 2) TsCl, Et3N, CH2Cl2], enantiomeric
excess of 11m (94% ee) was determined by chiral HPLC.
Umpolung Cyclization of (+)-13u under Pd(0)-Dppe
Catalysis (Scheme 14). To a solution of (S, E)-13u (20.8
mg, 0.084mmol) in anhydrous MeCN (0.05M) were added
Pd[P(o-tolyl)3]2 (6.0mg, 8.4¯mol), dppe (5.0mg, 13¯mol),
and HCO2H-Bu3N (9.5¯L­59¯L, 0.25mmol) under argon.
The resulting mixture was sealed with a screw cap and stirred at
50 °C for 1 d. Then the mixture was concentrated in vacuo. The
residue was purified by preparative TLC (10% EtOAc/toluene)
to afford (1R*, 2R*)-11u and (1S*, 2R*)-11u¤ (dr = 2:1, 24.9
mg, 0.072mmol, 86%) as a faster- and slower-moving com-
ponent, respectively. (1R*, 2R*)-11u was further purified by
chiral HPLC (Daicel Chiralpak OD-H, i-propanol/hexane =
1:10, 0.5mL/min, λ = 254 nm, recycled 3 times) to afford (1S,
2S)-11u (pseudo enantiomer) (tR = 26.2min) and (1R, 2R)-11u
(tR = 29.5min). 1HNMR analysis showed the respective inver-
sion and retention of the alkene geometries in (1S, 2S)- and
(1R, 2R)-11u. (1S*, 2R*)-11u¤ was further purified by chiral
HPLC (Daicel Chiralpak AS-H, i-propanol/hexane = 1:10,
0.5mL/min, λ = 254 nm, recycled 2 times) to afford (1R, 2S)-
11u¤ (tR = 10.1min) and (1S, 2R)-11u¤ (pseudo enantiomer)
(tR = 11.5min). 1HNMR analysis showed the respective reten-
tion and inversion of the alkene geometries in (1R, 2S)- and
(1S, 2R)-11u¤.
3. Results and Discussion
Effect of Reductant on the Allylic Acetate-Aldehyde
Cyclization. The effects of the reaction conditions on the
stereoselectivity of the reductive cyclization of allylic acetate-
aldehyde 13a were investigated and data are presented in
Table 1. As expected, the choice of the reductant crucially
influenced the enantioselective cyclization. Hydride sources
like formic acid in combination with tributylamine28 (Entry 1)
and triethylsilane (Entry 2) gave (3S, 4S)-11a in high yield
with excellent diastereo- and enantioselectivity.29 Interestingly,
the reduction of acetate24 to 16 or 16¤ (Scheme 2) was absent
under the reaction conditions. Meanwhile, organometallic rea-
gents including Et3B and Et2Zn employed in the intermolecular
variant4 lowered the yield and the optical purity of 11a (Entries
3 and 4). The use of THF as a solvent instead of acetonitrile
allowed partial enantioselectivity recovery by the borane rea-
gent, whereas that with zinc generated only a trace amount of
the product (Entries 5 and 6). Additionally, the Et2Zn failed
to promote the cyclization reaction even under Minnaard’s
reaction conditions.4b
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Similar to acetate 13a, carbonate 13b underwent cycliza-
tion even without an amine, because of in situ basic alkoxide
generation from the leaving group through decarboxylation30
(Table 2, Entries 1 and 2). The slightly lower reaction rate and
the product yield are attributed to the lower concentration of
the reductant. Similarly, an in situ generated hydride from the
leaving group of formate 13c enabled omission of the exter-
nal reductant, but seemed insufficient for the reaction rate
(Entry 3).24 The sluggish reaction was therefore accelerated
using an external formate salt (Entry 4). These results highlight
the necessity of a high concentration of the reductant for a rapid
catalytic cycle. Although formic acid also promoted the reduc-
tive cyclization of carbonate 13b and formate 13c, the trans-
diastereomer18a,18b,19c was also obtained as a minor product of
the 13c (Entries 2 vs. 5). Since acetic acid also lowered the
diastereoselectivity (Entry 6), protic media hinders the cyclic
transition state for high stereoselectivity.18d Variants of the
reaction conditions enabled reductive cyclization of other sub-
strates (vide infra).
Comparison of Solvent Effect. Since the reaction
conditions for the reductive cyclization were adapted to those
for the arylative cyclization of allene-aldehydes,12a acetonitrile,
the best solvent for the latter was chosen as the solvent.
Although the enantioselectivity of the allylic acetate-aldehyde
cyclization was unaffected by the aprotic solvent, that of allene-
aldehyde cyclization was partially affected (Table 3 vs.
Table 4). It is noteworthy that the protic media (i.e., methanol),
again caused low diastereoselectivity particularly in the former
cyclization (Table 3, Entry 5).
Excess organometallic reagent likely decreases enantio-
selectivity through the formation of neutral η1-allylpalladium
species like 17 in Scheme 3. The loss of enantioselectivity
observed in the THF (Table 4, Entry 2) was dramatically sup-
pressed by gradual addition of phenylboronic acid to maintain
Table 1. Effects of the reductant on the enantioselectivity of
allylic acetate-aldehyde cyclization.
TsN
OH
Ph
(3S, 4S)-11a
TsN
O
Ph
(±)-13a
AcO 10 mol% Pd[P(o-tolyl)3]2
15 mol% (S)-SEGPHOS
Reductant (3 equiv)
CH3CN (0.05 M), 50 °C
3
4
Entry Reductant Solvent
Time
(h)
Yield
(%)
Ee
(%)[a]
1[b] HCO2H-Bu3N CH3CN 4 87 95
2 Et3SiH CH3CN 6 78 94
3 Et3B[c] CH3CN 72 41 49
4 Et2Zn[d] CH3CN 36 11 79
5 Et3B[c] THF 72 43 83
6 Et2Zn[d] THF 36 trace ®
[a] Enantiomeric excess of cis-isomer 11a was determined by
chiral HPLC. [b] reported in ref. 16. [c] 5 equiv of Et3B was
used. [d] 3.5 equiv of Et2Zn was used.
Table 2. Effects of the leaving group on the reductive
cyclization.
TsN
OH
Ph
(3S, 4S)-11a
TsN
O
Ph
(±)-13b, c
X = OCO2Et (b), OCHO (c)
X 10 mol% Pd[P(o-tolyl)3]2
15 mol% (S)-SEGPHOS
Additive
CH3CN (0.05 M), 50 °C
3
4
Entry X Additive
Time
(h)
Yield
(%)
Ee
(%)[a]
1 OCO2Et
HCO2H-Bu3N
(3 equiv)
4 84 95
2[b] OCO2Et
HCO2H
(1 equiv)
7 70 90
3[b] OCHO None 72 54 91
4 OCHO
HCO2H-Bu3N
(1 equiv)
17 66 93
5 OCHO
HCO2H
(1 equiv)
24 60[c] 91
6 OCHO
AcOH
(1 equiv)
108 29[d] nd[e]
[a] Enantiomeric excess of cis-isomer 11a was determined by
chiral HPLC. [b] reported in ref. 16. [c] (¹)-Trans-isomer was
also obtained in 15% yield. [d] (¹)-Trans-isomer was also
obtained in 3% yield. [e] nd = not determined.
Table 3. Effects of the solvent on the enantioselectivity of
allylic acetate-aldehyde cyclization.
TsN
OH
Ph
(3S, 4S)-11a
TsN
O
Ph
(±)-13a
AcO 10 mol% Pd[P(o-tolyl)3]2
15 mol% (S)-SEGPHOS
HCO2H-Bu3N (3 equiv)
Solvent (0.05 M), 50 °C
3
4
Entry Solvent
Time
(h)
Yield
(%)
Dr
(cis:trans)[a]
Ee
(%)[b]
1[c] CH3CN 4 87 >20:1 95
2 THF 3 71 >20:1 95
3 DMF 6 69 >20:1 95
4 DCM 1.5 83 19:1 95
5 MeOH 48 70 3.7:1 90
[a] Diastereomeric ratio was determined by 1HNMR analysis
of a mixture of diastereomers. [b] Enantiomeric excess of cis-
isomer was determined by chiral HPLC. [c] reported in ref. 16.
Table 4. Effects of the solvent on the enantioselectivity of
allene-aldehyde cyclization.
TsN
OH
Ph
(3S, 4S)-11a
TsN
O
9a
10 mol% Pd(OAc)2
10 mol% (S)-SEGPHOS
PhB(OH)2 (1.5 equiv)
Solvent (0.1 M), 50 °C
3
4
Entry Solvent
Time
(h)
Yield
(%)
Dr
(cis:trans)[a]
Ee
(%)[b]
1[c] CH3CN 2 93 cis only 97
2 THF 2.5 81 18:1 77
3 DMF 5 84 >20:1 82
4 DCM 3 81 >20:1 86
5 MeOH 48 39 15:1 67
[a] Diastereomeric ratio was determined by 1HNMR analysis
of a mixture of diastereomers. [b] Enantiomeric excess of cis-
isomer 11a was determined by chiral HPLC. [c] reported in
ref. 12a.
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its low concentration (Scheme 4). The use of acetonitrile as a
solvent prevents cationic η1-allylpalladium intermediates from
further transmetalation because of its high coordination ability
to the palladium center.
Comparison of Diastereoselectivities. The best reaction
conditions for the reductive cyclization of sulfonamide-tethered
allylic acetate 13a (Tables 1 and 3, Entry 1), converted Boc-
protected nitrogen-tethered 13d into 11d in 53% yield and 90%
ee (data not shown). We presumed reduced electrophilicity
of the adjacent carbonyl group due to the weak electron-
withdrawing carbamate, causing lower chemical yield. Gratify-
ingly, slightly modified conditions involving more σ-donating
DM-SEGPHOS (12b) than SEGPHOS (12a) produced 11d in
much better yield, with retention of high enantioselectivity
(Scheme 5). The σ-donating phosphines aid the allyl ligand
to become nucleophilic rather than electrophilic. The DM-
SEGPHOS ligand also served effectively for reductive cycliza-
tion of other substrates 13e­i (Scheme 5). The oxygen-tethered
substrate 13e converted to cis-disubstituted tetrahydrofuran 11e
in high diastereo- and enantioselectivities. Unfortunately, the
diastereomeric ratio of five-membered carbocycles 11f and 11g,
and six-membered heterocycles 11h and 11i were cis/trans =
1.5:1­3.0:1, although diastereomers 11f­i and 11(f­i)¤ possess
high optical purities. The modified Mosher’s method26 revealed
the same absolute configuration for each pair of diastereomers
at the α-position of the hydroxyl group, and the opposite
stereochemistry substituted by the α-styryl group. It should be
noted that the treatment of the acetate counterparts of 13h and
13i with formic acid and tributylamine accompanied the for-
mation of side-products 1931 and 20, respectively, which were
derived from base-promoted β-elimination of sulfonamide
followed by reduction of η3-allylpalladium and Tsuji-Trost
type reaction, respectively (Figure 1). The base-free conditions
employed for the cyclization of the carbonate 13b (Table 2,
Entry 2) completely suppressed the side reactions and con-
verted carbonates 13h and 13i into cis- and trans-products 11h­
i and 11h­i¤. Moreover, the cyclization of tertiary allylic acetate
13j produced a 2:1 diastereomeric mixture of a quaternary
carbon-containing pyrrolidine 11j and 11j¤ in 90% and 70% ee,
respectively. The diastereoselectivity was significantly below
that of secondary allylic acetate 13a (Table 1, Entry 1).
These products are also obtained by the phenylative cycli-
zation of allene-aldehydes 9e­i (Scheme 6). Regardless of the
tethered atom and the length in the substrates, the latter cycli-
zation showed superior diastereoselectivity than the former,
generating cis-disubstituted tetrahydrofuran 11e, five-
membered carbocycles 11f and 11g, and six-membered hetero-
cycles 11h and 11i, exclusively or preferentially (Scheme 5 vs.
6). The two cyclizations showed comparably high enantio-
selectivities. In contrast, the phenylative cyclization of methyl-
substituted allene 9j was more diastereoselective, but less
enantioselective than the reductive equivalent of 13j to yield
common products 11j and 11j¤ containing a quaternary carbon.
Diastereoselectivities of the Reductive Cyclizations of
Isomeric Primary Allylic Acetate-Aldehydes. Further exper-
iments to understand the differences in the diastereoselectivities
of two types of the cyclizations were still required, because the
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Scheme 4. Effects of gradual addition of PhB(OH)2 on the
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CH3CN (0.05 M), 50 °C. a reductant = 3 equiv HCO2H–Bu3N. b reductant = 
1 equiv HCO2H. c (S)-SEGPHOS was used as a ligand. d reported in ref. 16.
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Scheme 5. The reductive cyclizations of aldehyde-containing
allylic acetates 13d­g¢j and carbonates 13h¢i.
TsHN
Ph
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Ph
O
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Figure 1. Side-products 19 and 20 obtained from the
acetate counterparts of 13h and 13i under basic conditions.
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use of secondary allylic acetates 13a and 13g renders the ratio
of the anti- and syn-η3-allylpalladium intermediates kinetically
generated in situ obscure. The stereo-defined η3-allylpalladi-
ums were prepared predominantly from the (Z)- and the (E)-
primary allylic acetates 13a¤ and 13g¤ (Scheme 7).32 Interest-
ingly, both of the nitrogen-tethered isomers (Z)- and (E)-13a¤
converted into cis-diastereomer 11a exclusively or preferen-
tially, although the latter substrate caused a slight decrease in
the optical purity of 11a. In contrast, the (Z)- and the (E)-allylic
acetates 13g¤ containing a carbon-tether also underwent cycli-
zation to produce diastereomeric mixtures of 11g and 11g¤, but
with reverse selectivity, i.e., 4.3:1 and 1:2.4, respectively. It is
noteworthy that minor diastereomers derived from primary
allylic acetates 13g¤ showed enantiomers of lower purity than
those from secondary allylic acetate 13g (Scheme 5).
Substituent Effect on the Allylic Acetate-Aldehyde Cycli-
zation. Since the arylative cyclization of allene-aldehydes
accompanies the introduction of a sterically demanding aryl
group into the allene central carbon,12a the steric effect of
the substituent at the C-2 in the allylpalladium moiety on the
diastereo- and enantioselectivities was unclear. In contrast
to the phenyl-substituted substrate 13a, the reaction of 2-
unsubstituted allylic acetate 13k (X = OAc) in the presence of
tributylammonium formate produced Tsuji-Trost type O-
allylation product 14k33 along with a diastereomeric mixture
of cyclized products 11k and 11k¤ (Table 5, Entry 1). While
the substitution of SEGPHOS (12a) with the σ-donating
DM-SEGPHOS (12b) did not prevent the formation of side-
product 14k (Entry 2), the combination of the carbonate 13j
(X = OCO2Me) and the formic acid caused suppression, gen-
erating 11k and 11k¤ in the highest combined yield (Entry 3).
These results indicated that the presence of an amine promoted
the formation of enolate, that is susceptible to electrophilic
allylation with the less hindered η3-allylpalladium. It is note-
condition B: 10 mol% Pd(OAc)2, 15 mol% (S )-SEGPHOS, 
1.5 equiv PhB(OH)2, CH3CN (0.1 M), 50 °C.
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Scheme 6. Highly diastereoselective phenylative cycliza-
tions of allene-aldehydes 9e­j.
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condition A: 10 mol% Pd[P(o-tolyl)3]2, 15 mol% (S)-DM-SEGPHOS, 
3 equiv HCO2H–Bu3N, CH3CN (0.05 M), 50 °C. a reported in ref. 16.
Scheme 7. Reductive cyclizations of (Z)- and (E)-primary
allylic acetates 13a¤ and 13g¤.
Table 5. Effect of the reaction conditions on the cyclization
of allylic acetate- or carbonate-aldehydes.
TsN
OH
H
(3S, 4S)-11k
TsN
O
H
(±)-13k
X 10 mol% Pd[P(o-tolyl)3]2
15 mol% 12a or 12b
Reductant
CH3CN (0.05 M), 50 °C
+ TsN
OH
H
(3S, 4R)-11k'
3
4
3
4
TsN O
H
14k
+
Entry X 12 Reductant
Yield[a]
of 11k
Yield[a]
of 11k¤
1[b] OAc 12a
HCO2H
-Bu3N
(3 equiv)
26%,
66% ee
6%,
55% ee
2[b] OAc 12b
HCO2H
-Bu3N
(3 equiv)
39%,
66% ee
7%,
55% ee
3 OCO2Me 12b
HCO2H
(1 equiv)
68%,
65% ee
15%,
57% ee
[a] Enantiomeric excess of 11k and 11k¤ was determined by
chiral HPLC. [b] 14k was obtained in 40% and 37% yields in
Entries 1 and 2, respectively.
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worthy that the enantiomeric ratio of the cis-product 11k was
below that of the phenyl-substituted 11a but was still good
(er = ca. 4.7:1). The lower enantioselectivity reflects a lower
difference in the activation energies of the Zimmerman-Traxler
transition states 10 and 10¤ (R = H) (Scheme 2).34 Gratify-
ingly, the enantiomerically enriched product 11k was obtained
by the reduction of chloro-substituted 11l,27 which was pre-
pared by the diastereo- and enantioselective cyclization of
isomeric allylic acetate 13l¤ (Scheme 8).16
The methyl-substituted allylic carbonate 13m also under-
went reductive cyclization to yield 4-(1-methylethenyl)-
pyrrolidin-3-ol derivative 11m, but with low enantioselectivity
(79% ee; Scheme 9, top). Instead, the use of di-carbonate
13n¤ solved the problem and produced the 11m in 94% ee after
one-pot reduction of in situ generated mono-carbonate 11n
(Scheme 9, bottom). A (methoxycarbonyloxy)methyl group in
13n¤ acted as a surrogate for the methyl group and improved
the enantioselectivity in the cyclization step.
The substitution of an aldehyde with a methyl ketone also
caused great loss in enantioselectivity (Scheme 10). This loss
is ascribed to steric repulsion between the methyl group and
pseudoequatorial phenyl group in the SEGPHOS ligand in
transition state 10 shown in Scheme 2. This phenomenon is
consistent with previous observations on the arylative cycliza-
tion of allene-ketone.12a
Plausible Mechanism of the Allylic Acetate-Aldehyde
Cyclization. The diastereoselectivities observed in the reduc-
tive cyclization of allylic acetate-aldehydes (Schemes 5 and 7)
provide clues to the generation and participation of allylpalla-
dium intermediates in the cyclization (Scheme 11). Oxidative
addition of allylic acetate («)-13 to Pd(0) produces anti- and
syn-η3-allylpalladiums 21 and 21¤, that are in equilibrium with
the (Z)- and the (E)-η1-allylpalladiums 22 and 22¤, respectively.
A sterically demanding substituent R in the allylic moiety
favors the anti-η3-allylpalladium 21 over the syn-complex 21¤
kinetically and thermodynamically through η1-allylpalladium
23.35 Contrarily, SN2- or SN2¤-type oxidative addition of the
(Z)- and the (E)-allylic acetates 13¤ to Pd(0) predominantly
generates anti- and syn-η3-allylpalladium 21 and 21¤, respec-
tively.32 Among the four six-membered transition states with R
groups oriented toward the upper left to avoid a steric repulsion
with the pseudoequatorial phenyl group in the (S)-SEGPHOS
ligand (see Scheme 2), chair-like transition states 24 and 25
are much more favorable than boat-like 24¤ and 25¤. The
Zimmerman-Traxler transition states 24 and 25 generate (1R,
2R)- and (1R, 2S)-cyclopentanols 11 and 11¤ (X = carbon),
respectively, whereas minor transition states 25¤ and 24¤ pro-
vide counter enantiomers to reduce the optical purity of each
diastereomer overall. Based on the experimental results on
the formation of five-membered carbocycles 11g and 11g¤
(Schemes 5 and 7), the ratios of (1R, 2R)-11g to (1S, 2R)-11g¤
and those of (1R, 2S)-11g¤ to (1S, 2S)-11g are estimated at 99/
1­97/3 and 94/6­92/8, respectively and reflect the degree of
contribution of the transition states 24/24¤ and 25/25¤. The
relatively lower optical purities of the minor diastereomers
trans-11g¤ and cis-11g prepared from the (Z)- and the (E)-
allylic acetates 13g¤ (Scheme 7) are attributed to partial partic-
ipation of the boat transition states 24¤ and 25¤. The reverse
diastereoselectivity observed in the cyclizations of the (Z)- and
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the (E)-13g¤ indicates that the isomerization of each η3-
allylpalladium to a primary η1-allylpalladium and the subse-
quent cyclization, are faster than the syn-anti isomerization
through the secondary η1-allylpalladium 23. In addition to
higher activation energies for transition states 25 and 25¤, SN2¤-
type oxidative addition of (Z)- and (E)-allylic acetates 13g¤,
which results in the direct formation of secondary η1-
allylpalladium 23 (an intermediate between 21 and 21¤ formed
via σ-bond rotation), may account for the incomplete diaster-
eoselectivity observed with a different relative ratio (4.3:1 vs.
1:2.4, Scheme 7).
To support the interpretation above, cyclic allylic acetates
13p and 13q were employed as the substrates because of the
provision of the geometrically fixed allyl complexes 21p¢q and
22p¢q (Scheme 12). Expectedly, the diastereoselective trans-
formation of 13p and 13q into spiro compounds 11p and 11q
was observed. The result demonstrates that the geometry of the
η3-allylpalladium intermediate considerably affects the diaster-
eoselectivity of the reductive cyclization reaction.
Meanwhile, the formation of five-membered heterocycles
accompanies a ring strain in the trans-fused 25 and 24¤. This
is explained by the shorter carbon-nitrogen and carbon-oxygen
relative to carbon-carbon bonds, that raises the acitavation
energy of 25 and 24¤ and dramatically increases the ratio of
the cis-11 to trans-11¤ (Scheme 11). Again, the slight reduced
optical purity of the cis-11a is attributed to participation of the
boat transition state 25¤ through the syn-η3-allylpalladium 21¤,
generated in higher quantities from (E)-allylic acetate 13a¤ than
the (Z)-isomer 13a¤ (Scheme 7). As illustrated in Scheme 5, an
elongation of the tether by a carbon releases the strain and
increases the amount of the trans-adduct 11h¤ and 11i¤. Low
diastereoselectivity observed in the cyclization of tertiary
allylic acetate 13j (Scheme 5) indicates that the methyl sub-
stituent would block the isomerization between anti- and syn-
η3-allylpalladiums with a little difference in thermodynamic
stabilities, which must be intermediated by tertiary η1-allylpal-
ladium 23¤ (Scheme 13) formed unlikely.32 In addition, a small
R group (R = H, Me; Scheme 11) reduces thermodynamic
stability of the anti-η3-allylpalladium 21 and the difference in
activation energies of the Zimmerman-Traxler transition states
10 and 10¤ (Scheme 2) yielding lower diastereo- and enantio-
selectivity (Table 5, Entry 3).
Plausible Mechanism of the Allene-Aldehyde Cyclization.
The arylative cyclization of allene-aldehyde 9 proceeds through
(Z)-η1-allylpalladium 22 (R = H, Me), that is kinetically
formed by carbopalladation of the terminal double bond in 9
from the less hindered face (Scheme 13).36,37 This retains the
high cis-selectivity even during the formation of cyclopenta-
nols 11f and 11g, six-membered heterocycles 11h and 11i, and
pyrrolidine 11j containing a tertiary carbon (Scheme 6).
The above reaction mechanism suggests that substitution
by R larger than a methyl group in Scheme 13 renders the
arylative cyclization of 1,1-disubstituted allenes less stereo-
selective. The isobutyl group in 9r in fact caused a significant
reduction in diastereo- and enantioselectivity (Table 6, Entries
1, 2 vs. 3). The low diastereoselectivity stems from the com-
petitive carbopalladation producing (E)-η1-allylpalladium 22¤
(Scheme 13). In the case of the 1,1-disubstituted allene, the
(E)-η1-allylpalladium 22¤ failed to undergo the isomerization
into (Z)-η1-allylpalladium 22, because it proceeds through an
unlikely tertiary η1-allylpalladium 23¤.32 Instead, the ring strain
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Table 6. Substituent effect on the stereoselectivity of allene-
aldehyde cyclization.
TsN 3
4TsN
O
9a j r: n =1
9h s t: n =2
10 mol% Pd(OAc)2
10 mol% (S)-SEGPHOS
PhB(OH)2 (1.5 equiv)
CH3CN (0.1 M), 50 °C
R
TsN
OH
Ph
(3S, 4S)-11
+
OH
Ph
(3S, 4R)-11'
R R
n n n
3
4
Entry 9 R
Yield
(%)
Dr
(cis:trans)[a]
Ee
(cis)[b]
Ee
(trans)[b]
1[c] 9a H 93 cis only 97% ®
2 9j Me 63 8.9:1 76% 41%
3 9r iso-Bu 80 2.4:1 37% 22%
4 9h H 85 19:1 98% 90%
5 9s Me 78 9.0:1 80% 70%
6 9t iso-Bu 59 2.9:1 71% 62%
[a] Diastereomeric ratio was determined by 1HNMR analysis
of a mixture of diastereomers. [b] Enantiomeric excess of 11
and 11¤ was determined by chiral HPLC. [c] reported in
ref. 12a.
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in the chair-TS 25 (X = NTs) relatively lowers the activa-
tion eneregies of boat TS-25¤ to generate (1S, 2S)-11, which
accounts for the low enantioselectivity of cis-11. Although the
reason for the trans-isomers 11j¤ and 11r¤ being much less
enantiomerically enriched than cis-isomers 11j and 11r
(Table 6, Entries 2 and 3) remains unclear, a disturbance in
the chair TS-25 caused by an alkyl group at the axial posi-
tion rather than the boat TS-24¤ contributed. In contrast, the
phenylative cyclization of the 9s and 9t homologues dramat-
ically restored enantioselectivity and retained diastereoselec-
tivity due to release of the ring strain in TS-25 (Table 6, Entries
2 vs. 5, 3 vs. 6 and Scheme 13).
Facial Selectivity of the Reductive Allylation of Alde-
hyde. The Zimmerman-Traxler transition states involved in
these cyclization reactions necessitate nucleophilic attacks of
the allylpalladium intermediates to the intramolecular alde-
hyde from the side occupied by the palladium. To trace the
facial selectivity, the chiral allylic acetate (S, E)-13u host-
ing (E)-deuterium-labeled alkene was utilized for cyclization
under achiral diphosphine (dppe)-ligated palladium catalysis
(Scheme 14). The oxidative addition of allylic acetate (S, E)-
13u to Pd(0) provided a mixture of the anti-21u and the syn-
21u¤ via a well-known inversion of the configuration.38 The η3-
η1 isomerization of the anti-21u and the syn-21u¤ produced (Z)-
and (E)-η1-allylpalladium 22u and 22u¤, respectively, generat-
ing (1R, 2R)-11u and (1S, 2R)-11u¤ retaining the alkene geom-
etry. In addition, the σ-bond rotations shown in Scheme 14 are
faster than the cyclizations and cause the formation of pseudo-
enantiomers of (1S, 2S)-11u and (1R, 2S)-11u¤ with inversion
of the alkene geometry (fast epimerization is requisite for the
asymmetric variant). In fact, each pseudo-diastereomer from
the crude pseudo-racemic mixture was isolated by preparative
TLC and separated by chiral HPLC to eventually produce four
stereoisomers. The absolute configurations were determined by
a modified Mosher’s method26 using MTPA esters of (1R, 2R)-
11f and (1R, 2S)-11f¤ (Scheme 5), which were parent non-
labeled counterparts of 11u and 11u¤. 1HNMR analysis of the
isomers revealed that each pair of pseudo-enantiomers (1R*,
2R*)-11u and (1R*, 2S*)-11u¤ has the reverse alkene geom-
etry. The distribution of these products was consistent with our
prediction.
4. Conclusion
This study has uncovered the differences between two asym-
metric umpolung cyclizations of aldehyde-containing allylpal-
ladium intermediates generated in situ by the oxidative addition
of allylic acetate and carbopalladation of allene. In the former
cyclization, the use of organometallic reductants like Et2Zn
and Et3B instead of formate and silane lowered the yield and
the optical purity of products. The effects of solvent on the
enantioselectivity were not observed in the former cyclization,
but in the latter. The enantioselectivity lowered by THF for the
latter cyclization was completely restored by gradual addition
of phenylboronic acid. This again indicates that the presence of
an excess organometallic reagent in the formation of a neutral
(η1-allyl)palladium complex causes loss of enantioselectivity.
Although the cyclization reactions produced common cis-
disubstituted five-membered heterocycles including pyrrolidine
and tetrahydrofuran, in excellent yields with high diastereo- and
enantioselectivity, different stereoselectivities were observed in
the formation of five-membered carbocycles, six-membered
heterocycles, and pyrrolidine containing a tertiary carbon.
Comparison between nitrogen- or carbon-tethered primary (Z)-
or (E)-allylic acetates 13a¤ and 13g¤, which leads to geometri-
cally defined η3-allylpalladium, disclosed that the highly
stereoselective formation of five-membered heterocycles in
the former cyclization can be ascribed to a ring strain in the
transition state to give trans-disubstituted one, and isomeriza-
tion of (E)- to (Z)-η1-allylpalladium through η3-η1-η3-complex.
The other different behaviors are attributed to the geometry of
allylpalladium species; these behaviors depend on how the
allylpalladium species is generated. The former cyclization
commences with the oxidative addition of secondary allylic
acetate to create geometrically obscure η3-allylpalladium. The
latter cyclization begins with carbopalladation of allene from
the less hindered side, directly forming primary (Z)-η1-allylpal-
ladium. The stereochemistry of products provided useful infor-
mation about allylpalladium intermediates which are difficult
to isolate and characterize. The Zimmerman-Traxler transition
state was supported by the chirality transfer reaction of the
optically active allylic acetate with deuterium-labeled alkene.
Further studies on another method that generates allylpalladium
intermediates via allylic C-H activation are underway.
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Scheme 14. Reductive cyclization of deuterium-labeled chi-
ral allylic acetate (S, E)-13u under Pd0-dppe catalysis.
Bull. Chem. Soc. Jpn. 2019, 92, 1743–1753 | doi:10.1246/bcsj.20190167 © 2019 The Chemical Society of Japan | 1751
Supporting Information
Detailed experimental procedures, spectroscopic data, and
copies of NMR spectra (PDF). This material is available on
https://doi.org/10.1246/bcsj.20190167.
References
1 a) P. W. Jolly, Angew. Chem., Int. Ed. Engl. 1985, 24, 283.
b) J. Tsuji, in Handbook of Organopalladium Chemistry for
Organic Synthesis, ed. by E. Negishi, Wiley, New York, 2002,
Vol. 2, p. 1669. doi:10.1002/0471212466.ch70. c) L. Acemoglu,
J. M. J. Williams, in Handbook of Organopalladium Chemistry
for Organic Synthesis, ed. by E. Negishi, Wiley, New York, 2002,
Vol. 2, p. 1689. doi:10.1002/0471212466.ch71. d) G. Poli, G.
Prestat, F. Liron, C. Kammerer-Pentier, Top. Organomet. Chem.
2012, 38, 1.
2 a) Y. Tamaru, J. Organomet. Chem. 1999, 576, 215. b) J. A.
Marshall, Chem. Rev. 2000, 100, 3163. c) K. J. Szabó, Chem.®
Eur. J. 2004, 10, 5268. d) Y. Yamamoto, I. Nakamura, Top.
Organomet. Chem. 2005, 14, 211. e) H. C. Malinakova, Lett. Org.
Chem. 2006, 3, 82. f ) G. Zanoni, A. Pontiroli, A. Marchetti, G.
Vidari, Eur. J. Org. Chem. 2007, 3599. g) M. Jeganmohan, C.-H.
Cheng, Chem. Commun. 2008, 3101. h) K. Spielmann, G. Niel,
R. M. de Figueiredo, J.-M. Campagne, Chem. Soc. Rev. 2018, 47,
1159.
3 a) B. M. Trost, D. L. Van Vranken, Chem. Rev. 1996, 96,
395. b) B. M. Trost, D. R. Fandrick, Aldrichimica Acta 2007, 40,
59. c) B. M. Trost, M. L. Crawley, Chem. Rev. 2003, 103, 2921.
d) B. M. Trost, M. L. Crawley, Top. Organomet. Chem. 2011, 38,
321. e) T. Hayashi, J. Organomet. Chem. 1999, 576, 195. f ) T.
Hayashi, Acc. Chem. Res. 2000, 33, 354.
4 a) G. Zanoni, S. Gladiali, A. Marchetti, P. Piccinini, I.
Tredici, G. Vidari, Angew. Chem., Int. Ed. 2004, 43, 846. b) G. P.
Howell, A. J. Minnaard, B. L. Feringa, Org. Biomol. Chem. 2006,
4, 1278. c) S.-F. Zhu, Y. Yang, L.-X. Wang, B. Liu, Q.-L. Zhou,
Org. Lett. 2005, 7, 2333. d) S.-F. Zhu, X.-C. Qiao, Y.-Z. Zhang,
L.-X. Wang, Q.-L. Zhou, Chem. Sci. 2011, 2, 1135. e) X.-C. Qiao,
S.-F. Zhu, W.-Q. Chen, Q.-L. Zhou, Tetrahedron: Asymmetry 2010,
21, 1216. f ) T.-Z. Zhang, L.-X. Dai, X.-L. Hou, Tetrahedron:
Asymmetry 2007, 18, 251. g) J.-J. Jiang, D. Wang, W.-F. Wang,
Z.-L. Yuan, M.-X. Zhao, F.-J. Wang, M. Shi, Tetrahedron:
Asymmetry 2010, 21, 2050.
5 a) K. Nakamura, H. Nakamura, Y. Yamamoto, J. Org.
Chem. 1999, 64, 2614. b) R. A. Fernandes, A. Stimac, Y.
Yamamoto, J. Am. Chem. Soc. 2003, 125, 14133. c) R. A.
Fernandes, Y. Yamamoto, J. Org. Chem. 2004, 69, 735. d) R. A.
Fernandes, Y. Yamamoto, J. Org. Chem. 2004, 69, 3562.
6 a) H. Nakamura, H. Iwama, Y. Yamamoto, J. Am. Chem.
Soc. 1996, 118, 6641. b) H. Nakamura, M. Bao, Y. Yamamoto,
Angew. Chem., Int. Ed. 2001, 40, 3208.
7 a) N. Solin, J. Kjellgren, K. J. Szabó, J. Am. Chem. Soc.
2004, 126, 7026. b) N. Solin, O. A. Wallner, K. J. Szabó, Org. Lett.
2005, 7, 689. c) O. A. Wallner, K. J. Szabó, Chem.®Eur. J. 2006,
12, 6976. d) J. Li, A. J. Minnaard, R. J. M. K. Gebbink, G.
van Koten, Tetrahedron Lett. 2009, 50, 2232.
8 a) O. A. Wallner, V. J. Olsson, L. Eriksson, K. J. Szabó,
Inorg. Chim. Acta 2006, 359, 1767. b) J. Aydin, K. S. Kumar, M. J.
Sayah, O. A. Wallner, K. J. Szabó, J. Org. Chem. 2007, 72, 4689.
9 N. T. Barczak, R. E. Grote, E. R. Jarvo, Organometallics
2007, 26, 4863.
10 W. Wang, T. Zhang, M. Shi, Organometallics 2009, 28,
2640.
11 a) C. D. Hopkins, H. C. Malinakova, Org. Lett. 2004, 6,
2221. b) C. D. Hopkins, L. Guan, H. C. Malinakova, J. Org. Chem.
2005, 70, 6848. c) C. D. Hopkins, H. C. Malinakova, Org. Lett.
2006, 8, 5971. d) X. Yu, X. Lu, Org. Lett. 2009, 11, 4366. e) X. Yu,
X. Lu, J. Org. Chem. 2011, 76, 6350.
12 a) H. Tsukamoto, T. Matsumoto, Y. Kondo, Org. Lett. 2008,
10, 1047. b) X. Zhang, X. Han, X. Liu, Org. Lett. 2015, 17, 3910.
13 Ru-catalyzed carbonyl allylation with carbon monoxide
as reductant: a) Y. Tsuji, T. Mukai, T. Kondo, Y. Watanabe,
J. Organomet. Chem. 1989, 369, C51. b) T. Kondo, H. Ono, N.
Satake, T. Mitsudo, Y. Watanabe, Organometallics 1995, 14, 1945.
c) S. E. Denmark, S. T. Nguyen, Org. Lett. 2009, 11, 781. d) C.-M.
Yu, S. Lee, Y.-T. Hong, S.-K. Yoon, Tetrahedron Lett. 2004, 45,
6557.
14 Ir-catalyzed enantioselective intermolecular carbonyl allyl-
ation with isopropanol as a reductant: a) I. S. Kim, M.-Y. Ngai,
M. J. Krische, J. Am. Chem. Soc. 2008, 130, 6340. b) I. S. Kim,
M.-Y. Ngai, M. J. Krische, J. Am. Chem. Soc. 2008, 130, 14891.
15 Bimetal-catalyzed non-asymmetric cyclization: a) B. M.
Trost, K. D. Moeller, Heterocycles 1989, 28, 321. b) N. Maezaki,
H. Fukuyama, S. Yagi, T. Tanaka, C. Iwata, J. Chem. Soc., Chem.
Commun. 1994, 1835. c) W. Oppolzer, F. Flachsmann, Helv. Chim.
Acta 2001, 84, 416. d) V. C. Nguyen, Y.-T. Kim, Y.-K. Yu, H.-Y.
Kang, Bull. Korean Chem. Soc. 2005, 26, 711. e) A. G. Campaña,
B. Bazdi, N. Fuentes, R. Robles, J. M. Cuerva, J. E. Oltra, S.
Porcel, A. M. Echavarren, Angew. Chem., Int. Ed. 2008, 47, 7515.
f ) A. Millán, A. G. Campaña, B. Bazdi, D. Miguel, L.
Álvarez de Cienfuegos, A. M. Echavarren, J. M. Cuerva,
Chem.®Eur. J. 2011, 17, 3985.
16 H. Tsukamoto, A. Kawase, T. Doi, Chem. Commun. 2015,
51, 8027.
17 a) Y. Yamamoto, N. Asao, Chem. Rev. 1993, 93, 2207.
b) S. E. Denmark, J. Fu, Chem. Rev. 2003, 103, 2763.
18 Pd0-catalyzed arylative cyclization with aryl iodides and
distannane or In: a) S.-K. Kang, S.-W. Lee, J. Jung, Y. Lim, J. Org.
Chem. 2002, 67, 4376. b) Y.-H. Ha, S.-K. Kang, Org. Lett. 2002, 4,
1143. See also silylative and stannylative cyclization: c) S.-K.
Kang, Y.-H. Ha, B.-S. Ko, Y. Lim, J. Jung, Angew. Chem., Int. Ed.
2002, 41, 343. d) C.-M. Yu, J. Youn, M.-K. Lee, Org. Lett. 2005, 7,
3733. e) S.-K. Kang, Y.-T. Hong, J.-H. Lee, W.-Y. Kim, I. Lee,
C.-M. Yu, Org. Lett. 2003, 5, 2813.
19 Ni0-catalyzed alkylative cyclization with organozinc rea-
gents: a) J. Montgomery, M. Song, Org. Lett. 2002, 4, 4009. b) M.
Song, J. Montgomery, Tetrahedron 2005, 61, 11440. c) S.-K.
Kang, S.-K. Yoon, Chem. Commun. 2002, 2634.
20 H. Shimizu, I. Nagasaki, K. Matsumura, N. Sayo, T. Saito,
Acc. Chem. Res. 2007, 40, 1385.
21 a) H. Kurosawa, A. Urabe, Chem. Lett. 1985, 1839. b) H.
Kurosawa, A. Urabe, K. Miki, N. Kasai, Organometallics 1986, 5,
2002.
22 J.-E. Bäckvall, J.-O. Vågberg, K. L. Granberg, Tetrahedron
Lett. 1989, 30, 617.
23 a) Y. T. Han, N.-J. Kim, J.-W. Jung, H. Yun, S. Lee, Y.-G.
Suh, Arch. Pharmacal Res. 2011, 34, 1437. b) J. Agarwal, C.
Commandeur, M. Malacria, S. Thorimbert, Tetrahedron 2013, 69,
9398.
24 J. Tsuji, T. Mandai, Synthesis 1996, 1.
25 Rh-catalyzed ones: a) X.-X. Guo, T. Sawano, T. Nishimura,
T. Hayashi, Tetrahedron: Asymmetry 2010, 21, 1730. Ru-catalyzed
one: b) ref 13d.
26 The absolute configurations of major enantiomers were
1752 | Bull. Chem. Soc. Jpn. 2019, 92, 1743–1753 | doi:10.1246/bcsj.20190167 © 2019 The Chemical Society of Japan
determined by Mosher’s method. a) I. Ohtani, T. Kusumi, Y.
Kashman, H. Kakisawa, J. Am. Chem. Soc. 1991, 113, 4092.
b) J. A. Dale, D. L. Dull, H. S. Mosher, J. Org. Chem. 1969, 34,
2543. c) J. A. Dale, H. S. Mosher, J. Am. Chem. Soc. 1973, 95,
512.
27 C. Zhang, X. Li, H. Sun, Inorg. Chim. Acta 2011, 365, 133.
28 a) N. A. Cortese, R. F. Heck, J. Org. Chem. 1978, 43, 3985.
b) S. Cacchi, E. Morera, G. Ortar, Tetrahedron Lett. 1984, 25,
4821.
29 The lower catalyst loading (5mol%) resulted in longer
reaction time (12 h) and lower yield (76% of 11a).
30 a) J. Tsuji, I. Shimizu, I. Minami, Y. Ohashi, Tetrahedron
Lett. 1982, 23, 4809. b) J. Tsuji, I. Shimizu, I. Minami, Y. Ohashi,
T. Sugiura, K. Takahashi, J. Org. Chem. 1985, 50, 1523. c) J. Tsuji,
I. Minami, Acc. Chem. Res. 1987, 20, 140.
31 a) G. Kresze, U. Wagner, Liebigs Ann. Chem. 1972, 762,
93. b) C. Zhang, S.-Q. Zhang, H.-J. Cai, D.-M. Cui, Beilstein J.
Org. Chem. 2013, 9, 1045.
32 M. Kawatsura, Y. Uozumi, M. Ogasawara, T. Hayashi,
Tetrahedron 2000, 56, 2247.
33 a) F. Cambeiro, S. López, J. A. Varela, C. Saá, Angew.
Chem., Int. Ed. 2014, 53, 5959. b) Y. Wang, W.-Y. Zhang, S.-L.
You, J. Am. Chem. Soc. 2019, 141, 2228.
34 Even in case of R = H, a leaning toward the left and right
in Zimmerman-Traxler transition states 10 and 10¤, respectively
would favor 10.
35 a) J. W. Faller, M. E. Thomsen, M. J. Mattina, J. Am. Chem.
Soc. 1971, 93, 2642. b) J. W. Faller, M. T. Tully, K. J. Laffey,
J. Organomet. Chem. 1972, 37, 193.
36 Regioselective carbopalladation of allenes usually produce
C2-carbon-substituted π-allylpalladium(II): a) B. Cazes, Pure
Appl. Chem. 1990, 62, 1867. b) S. Ma, Pure Appl. Chem. 2006,
78, 197. c) S. Ma, Acc. Chem. Res. 2003, 36, 701. d) R. W. Bates,
V. Satcharoen, Chem. Soc. Rev. 2002, 31, 12. e) R. Zimmer, C. U.
Dinesh, E. Nandanan, F. A. Khan, Chem. Rev. 2000, 100, 3067.
f ) G. Balme, E. Bossharth, N. Monteiro, Eur. J. Org. Chem. 2003,
4101.
37 a) T. Bai, L. Xue, P. Xue, J. Zhu, H. H.-Y. Sung, S. Ma,
I. D. Wiliams, Z. Lin, G. Jia, Organometallics 2008, 27, 2614.
b) M. Yoshida, K. Matsuda, Y. Shoji, T. Gotou, M. Ihara, K.
Shishido, Org. Lett. 2008, 10, 5183. c) T.-H. Huang, H.-M. Chang,
M.-Y. Wu, C.-H. Chang, J. Org. Chem. 2002, 67, 99.
38 T. Hayashi, T. Hagihara, M. Konishi, M. Kumada, J. Am.
Chem. Soc. 1983, 105, 7767.
Bull. Chem. Soc. Jpn. 2019, 92, 1743–1753 | doi:10.1246/bcsj.20190167 © 2019 The Chemical Society of Japan | 1753
